Send feedback

CFI p.Leu131Arg

c.392T>G · VCV4280513

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.3306 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000339%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
atypical hemolytic-uremic syndrome

Computational evidence

Protein change
AlphaMissense0.3306likely benign
REVEL0.281benign-leaning
SaProtLLR -6.28tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.3GERP 1.8, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 61 kb · p 0.95 · regional, not allelic
Overall
CADD23.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000339% European (non-Finnish) · 4/1,180,004 alleles
Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.00031% 5/1,613,976 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,486
European (non-Finnish)grpmax 0.000339% 295,001

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CFI
Protein
p.Leu131Arg
Coding
c.392T>G
MANE Select
NM_000204
Type
single nucleotide variant
Location
chr4:109764627 (GRCh38)
Gene constraint
LOEUF 1.076 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.50 · 2 PDB
Residue 131
a disulfide bond; the srcr domain
Full CFI gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

atypical hemolytic-uremic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Atypical hemolytic uremic syndrome (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfi-p-leu131arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown